Replies to post #244011 on Innovation Pharmaceuticals Inc (IPIX)

[lousy engineer]

It was last updated in a corporate update back in 9/20. Probably a month or more than a month into the review by now.

In coming weeks, the Company plans to submit a request for an End-of-Phase 2 meeting with the Food and Drug Administration (FDA) to discuss appropriate next steps in the development of Brilacidin for the treatment of Oral Mucositis (OM), which has already been granted Fast Track designation. A Breakthrough Therapy Designation application is currently under review with the FDA.

http://www.ipharminc.com/press-release/2018/9/20/innovation-pharmaceuticals-provides-corporate-update-highlighting-upcoming-milestones-and-events